遗传性运动神经病的遗传异质性研究
该研究对英格兰北部105例遗传性运动神经病患者进行神经电生理评估和基因检测,发现dHMN患病率为2.14/10万,73例先证者中35.6%检出致病突变,dHMN与CMT2共享致病基因,部分病例存在神经肌肉传递缺陷。
要点
- dHMN在英格兰北部患病率为2.14/10万(95%CI 1.62-2.66)。
- 73例先证者中26例(35.6%)检出致病突变,dHMN亚组诊断率32.5%。
- dHMN与CMT2共享致病基因,建议将dHMN归为CMT亚类。
核心结论
- dHMN与运动型CMT2共享致病基因,提示相同疾病机制,建议将dHMN归为Charcot-Marie-Tooth病的亚类。
- 部分遗传性运动神经病存在神经肌肉传递缺陷,为开发治疗提供可干预靶点。
研究设计与样本
- 对英格兰北部105例临床诊断为dHMN(64例)、轴索型运动神经病CMT2(16例)或复杂运动神经病(25例)的患者进行详细神经电生理评估和基因panel检测或全外显子测序。
主要发现
- dHMN患病率为2.14/10万(95%CI 1.62-2.66)。
- 73例先证者中26例(35.6%)检出致病突变,dHMN亚组诊断率32.5%,高于既往报道的20%。
- 7例检出显著神经肌肉传递缺陷,4例多灶性脱髓鞘运动神经病检出可能致病突变。
临床怎么用
- 对dHMN患者应进行基因检测,诊断率可达32.5%。
- 对遗传性运动神经病患者应评估神经肌肉传递功能,以识别可治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the prevalence, molecular cause, and clinical presentation of hereditary motor neuropathies in a large cohort of patients from the North of England. METHODS: Detailed neurologic and electrophysiologic assessments and next-generation panel testing or whole exome sequencing were performed in 105 patients with clinical symptoms of distal hereditary motor neuropathy (dHMN, 64 patients), axonal motor neuropathy (motor Charcot-Marie-Tooth disease [CMT2], 16 patients), or complex neurologic disease predominantly affecting the motor nerves (hereditary motor neuropathy plus, 25 patients). RESULTS: The prevalence of dHMN is 2.14 affected individuals per 100,000 inhabitants (95% confidence interval 1.62-2.66) in the North of England. Causative mutations were identified in 26 out of 73 index patients (35.6%). The diagnostic rate in the dHMN subgroup was 32.5%, which is higher than previously reported (20%). We detected a significant defect of neuromuscular transmission in 7 cases and identified potentially causative mutations in 4 patients with multifocal demyelinating motor neuropathy. CONCLUSIONS: Many of the genes were shared between dHMN and motor CMT2, indicating identical disease mechanisms; therefore, we suggest changing the classification and including dHMN also as a subcategory of Charcot-Marie-Tooth disease. Abnormal neuromuscular transmission in some genetic forms provides a treatable target to develop therapies.
引用
- Bansagi B, Griffin H, Whittaker RG, et al. Genetic heterogeneity of motor neuropathies. Neurology. 2017. PMID: 28251916. doi:10.1212/WNL.0000000000003772
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。